Market Access/ News/ News Scynexis bids to end novel antifungal drought, filing ibrexafungerp in US Phil Taylor #scynexis, antifungal, fda, infectious disease 0 Comment Scynexis has filed for FDA approval of its novel drug ibrexafungerp which – if approved – would be Share X Scynexis bids to end novel antifungal drought, filing ibrexafungerp in US https://pharmaphorum.com/news/scynexis-bids-to-end-novel-antifungal-drought/
Partner content/ Press releases Final Reminder: 1 Week Until SMi’s Superbugs & Superdrugs Conference USA Jinna Sidhu #scynexis, #smibugs, healthcare, pharma, regulation 0 Comment 12 – 13 November 2018 Iselin, New Jersey www.superbugs-usa.com/press Sponsored by Scynexis The issue of antibacterial resistance is Share X Final Reminder: 1 Week Until SMi’s Superbugs & Superdrugs Conference USA https://pharmaphorum.com/partner-content/final-reminder-1-week-until-smis-superbugs-superdrugs-conference-usa/
Partner Content/ Partner content/ Press releases Antibiotic Class Emerges through Digestive Enzyme Teri Arri #scynexis, healthcare, medical devices, pharma, regulation 0 Comment Drug-resistant organisms kill an estimated 23,000 people in the U.S. every year, and it is predicted that by Share X Antibiotic Class Emerges through Digestive Enzyme https://pharmaphorum.com/partner-content/antibiotic-class-emerges-through-digestive-enzyme/
#scynexis, #smibugs, healthcare, pharma, regulation
0 Comment
